Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas
✍ Scribed by Karsten Müssig; Tobias Wehrmann; Helmut Dittmann; Manfred Wehrmann; Bianca Ueberberg; Stefan Schulz; Roland Bares; Stephan Petersenn
- Book ID
- 114720447
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 436 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0300-0664
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The number of mitoses and, thus, the proliferative capacity of a tumor is one of the most crucial variables for tumor grading. The Ki‐67 nuclear antigen may be considered as an alternative to mitotic counts in grading schemes and as a single parameter that can be used in
Integrin dimer alpha 6 beta 4 is a transmembrane component of an epithelial cell adhesion complex that consists of hemidesmosomes (HDs), basement membrane (BM)-associated laminin-5 (Ln-5), and anchoring filaments/type VII collagen, all of which are absent from normal thyroid follicular epithelium. I